Latest BioAlps news
News
Bewe’s Biopôle journey comes full circle with Pre-Clinical Top-Up
Biopôle SA is delighted to announce that Bewe has been awarded the Pre-Clinical Top-Up, marking the next phase of a…
News
Spineart and eCential Robotics receive FDA clearance for the PERLA® TL application
Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug…
News
Adaptyv raises $40M Series A to build the automated lab for agentic biology
The Biopôle-based startup announced a $40M Series A funding round to build the automated lab for agentic biology, led by…
News
Spineart Announces FDA Approval ofBAGUERA® C Cervical Disc
Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the…
News
Bruker expands its collaboration with Atinary and makes a minority investment
Bruker Corporation (NASDAQ:BRKR) announced that it is expanding its strategic collaboration with Atinary Technologies Inc., and acquiring a minority stake…
News
Alcon Halts Intraocular Lens Programmes After $402 Million Writedown
Alcon, the Geneva-based global leader in eye care, announced on Monday evening that it is discontinuing its intraocular lens (IOL)…
News
Oculis Secures FDA Backing and Full Ownership of Privosegtor
Oculis Holding AG, a Zug-based biopharmaceutical company with operations in Lausanne, has had a decisive first two weeks of August…
News
SOPHiA GENETICS Enters Collaboration With AstraZeneca to Develop Companion Diagnostics for Precision Oncology Therapies
The Vaud-based AI-native healthcare technology company announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx)…
News
Timeline Wins $5.3 Million Court Judgment Against Fake Urolithin A Sellers
Timeline (Amazentis SA), the Lausanne-Based life-sciences company behind the postbiotic ingredient Urolithin A and its branded form Mitopure®, has secured…
News
HAYA Therapeutics granted Fast Track designation by the FDA for HTX-001
HAYA Therapeutics SA, a clinical-stage biotechnology company based in Lausanne and San Diego, announced that the US Food and Drug…
News
AB2 Bio Secures $30 Million as Nippon Shinyaku Exercises US Commercialization Rights for Tadekinig Alfa
AB2 Bio, a Swiss Health Valley and EPFL based company, has announced that Nippon Shinyaku has exercised its exclusive option…
News
HeroSupport Starts Clinical Study With NYU Grossman School of Medicine
HeroSupport SA is a UNIGE and HUG spin out and created VENUS SHELL™ , a 3D-printed support that enables accurate,…











